Home / Companies / News / Experts suggest policy changes to boost coronavirus research & development

Experts suggest policy changes to boost coronavirus research & development

Funding Covid-related research now included in CSR spends

r&d, coronavirus, vaccine, research & development

Premium

Pharma industry insiders, however, have pointed out that by limiting such collaborations to only public institutions, the Centre has limited its scope

Sohini Das Vinay Umarji Mumbai/Ahmedabad

4 min read Last Updated : Aug 29 2020 | 6:03 AM IST

Calls for development of a research ecosystem have been getting louder, as a consequence of the pandemic.

An expert group — comprising industry doyens, senior government officials, and academia — has submitted a detailed report to the government explaining the policy changes required to boost research and development (R&D) in the pharmaceutical space. The government had, on Tuesday, said it was temporarily allowing investments in R&D for Covid-19 drugs and vaccines as fulfilment of a company’s corporate social responsibility (CSR) obligations.

Pharma industry insiders, however, have pointed out that by limiting such collaborations to only public institutions, the Centre has limited its

Topics : Coronavirus India's R&D spending Corporate social responsibility

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in